Ring Therapeutics

Ring Therapeutics is a multi-product platform company dedicated to the discovery and development of Anellovector therapeutics, focusing on creating a vector therapy to fully unlock the potential of gene therapy. By leveraging the biological characteristics of human commensal viruses, Ring has pioneered the first re-dosable and targetable gene therapy platform. The company is expanding the application of gene therapy beyond gene replacement, offering broader approaches and mechanisms for treating previously incurable diseases. Ring Therapeutics is broadening the scope of gene therapy applications beyond gene replacement, enabling more extensive methods and mechanisms for treating diseases that were previously inaccessible.